1.35BMarket Cap-8281P/E (TTM)
22.790High20.570Low1.14MVolume21.150Open20.240Pre Close25.16MTurnover2.22%Turnover RatioLossP/E (Static)61.07MShares22.79052wk High7.97P/B1.13BFloat Cap4.22052wk Low--Dividend TTM51.41MShs Float52.380Historical High--Div YieldTTM10.97%Amplitude4.220Historical Low22.027Avg Price1Lot Size
Nurix Therapeutics Stock Forum
as this guy 👇
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
Nurix said patients currently enrolled in the trial who are deriving clinical benefit are allowed to continue receiving the current drug product. The screening and enrollment of new patients has been paused.
The company sai...
No comment yet